These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19108934)

  • 1. Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle.
    Shtifman A; Ward CW; Laver DR; Bannister ML; Lopez JR; Kitazawa M; LaFerla FM; Ikemoto N; Querfurth HW
    Neurobiol Aging; 2010 Dec; 31(12):2080-90. PubMed ID: 19108934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular β-amyloid accumulation leads to age-dependent progression of Ca2+ dysregulation in skeletal muscle.
    Lopez JR; Shtifman A
    Muscle Nerve; 2010 Nov; 42(5):731-8. PubMed ID: 20665519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.
    Boncompagni S; Moussa CE; Levy E; Pezone MJ; Lopez JR; Protasi F; Shtifman A
    J Biol Chem; 2012 Jun; 287(24):20534-44. PubMed ID: 22518836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology.
    Moussa CE; Fu Q; Kumar P; Shtifman A; Lopez JR; Allen PD; LaFerla F; Weinberg D; Magrane J; Aprahamian T; Walsh K; Rosen KM; Querfurth HW
    FASEB J; 2006 Oct; 20(12):2165-7. PubMed ID: 16940437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy.
    Querfurth HW; Suhara T; Rosen KM; McPhie DL; Fujio Y; Tejada G; Neve RL; Adelman LS; Walsh K
    Mol Cell Neurosci; 2001 May; 17(5):793-810. PubMed ID: 11358479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdomain interactions within ryanodine receptors regulate Ca2+ spark frequency in skeletal muscle.
    Shtifman A; Ward CW; Yamamoto T; Wang J; Olbinski B; Valdivia HH; Ikemoto N; Schneider MF
    J Gen Physiol; 2002 Jan; 119(1):15-32. PubMed ID: 11773235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle.
    Laver DR; Roden LD; Ahern GP; Eager KR; Junankar PR; Dulhunty AF
    J Membr Biol; 1995 Sep; 147(1):7-22. PubMed ID: 8531200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.
    Bussiere R; Lacampagne A; Reiken S; Liu X; Scheuerman V; Zalk R; Martin C; Checler F; Marks AR; Chami M
    J Biol Chem; 2017 Jun; 292(24):10153-10168. PubMed ID: 28476886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice.
    Kitazawa M; Green KN; Caccamo A; LaFerla FM
    Am J Pathol; 2006 Jun; 168(6):1986-97. PubMed ID: 16723713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors.
    Robinson K; Culley D; Waring S; Lamb GD; Easton C; Casarotto MG; Dulhunty AF
    Life Sci; 2020 Nov; 260():118234. PubMed ID: 32791148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid toxicity in skeletal myoblasts: Implications for inclusion-body myositis.
    Jayaraman M; Kannayiram G; Rajadas J
    Arch Biochem Biophys; 2008 Jun; 474(1):15-21. PubMed ID: 18397759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model.
    Kitazawa M; Vasilevko V; Cribbs DH; LaFerla FM
    J Neurosci; 2009 May; 29(19):6132-41. PubMed ID: 19439591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model.
    Sugarman MC; Kitazawa M; Baker M; Caiozzo VJ; Querfurth HW; LaFerla FM
    Neurobiol Aging; 2006 Mar; 27(3):423-32. PubMed ID: 15950323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
    Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
    Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes.
    Christensen RA; Shtifman A; Allen PD; Lopez JR; Querfurth HW
    J Biol Chem; 2004 Dec; 279(51):53524-32. PubMed ID: 15385569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle.
    Ahern GP; Junankar PR; Pace SM; Curtis S; Mould JA; Dulhunty AF
    J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):313-26. PubMed ID: 9852316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells.
    Querfurth HW; Jiang J; Geiger JD; Selkoe DJ
    J Neurochem; 1997 Oct; 69(4):1580-91. PubMed ID: 9326287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R4496C RyR2 mutation impairs atrial and ventricular contractility.
    Ferrantini C; Coppini R; Scellini B; Ferrara C; Pioner JM; Mazzoni L; Priori S; Cerbai E; Tesi C; Poggesi C
    J Gen Physiol; 2016 Jan; 147(1):39-52. PubMed ID: 26666913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle.
    Treves S; Scutari E; Robert M; Groh S; Ottolia M; Prestipino G; Ronjat M; Zorzato F
    Biochemistry; 1997 Sep; 36(38):11496-503. PubMed ID: 9298970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.
    Sugarman MC; Yamasaki TR; Oddo S; Echegoyen JC; Murphy MP; Golde TE; Jannatipour M; Leissring MA; LaFerla FM
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6334-9. PubMed ID: 11972038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.